Akcea Therapeutics, Inc. logo

Akcea Therapeutics (AKCA) stock

AKCA · Akcea Therapeutics, Inc. · NASDAQ

What is the latest news on AKCA stock?

PRago
Contineum Therapeutics Announces Appointment of Sarah Boyce to Board of Directors

Contineum Therapeutics, Inc. (NASDAQ:CTNM), a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments for the treatment of neuroscience, inflammation and immunology (NI&I) indications, today announced the appointment of Sarah Boyce, President and Chief Executive Officer of Avidity Biosciences, Inc. (NASDAQ:RNA), as an independent member of its Board of Directors. Ms. Boyce brings over 25 years of global commercial and clinical development expertise in the life sciences industry to Contineum's board. Ms. Boyce has extensive expertise in global pharmaceut

All AKCA news

Latest news

8 items

Akcea Therapeutics, Inc. (AKCA) is a Major Pharmaceuticals company listed on NASDAQ. There were no new wire items for AKCA in the last 30 days. The most recent was published Jun 24, 2024.

AKCA FAQ

5 questions
  • Where does AKCA stock trade?
    Akcea Therapeutics, Inc. (AKCA) is listed on NASDAQ.
  • What sector and industry is AKCA in?
    Akcea Therapeutics, Inc. operates in the Health Care sector, Major Pharmaceuticals industry.
  • When did Akcea Therapeutics, Inc. go public?
    Akcea Therapeutics, Inc. (AKCA) completed its IPO in 2017.
  • What companies are similar to AKCA?
    Notable peers in the same industry include ADMS (Adamas Pharmaceuticals, Inc.), ADRO (Aduro Biotech, Inc.), ADXS (Advaxis, Inc.), ARPO (Aerpio Pharmaceuticals, Inc.), AIMT (Aimmune Therapeutics, Inc.). Compare AKCA side-by-side with any of them on Quantisnow.
  • How can I track AKCA on Quantisnow?
    Quantisnow aggregates Akcea Therapeutics, Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow AKCA to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change